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AbstrAct
background: The skin-sparing effect of megavoltage-photon beams in radiotherapy (rT) reduces the target coverage of 
superficial tumours. consequently, a bolus is widely used to enhance the target coverage for superficial targets. This study 
evaluates a three-dimensional (3D)-printed customized bolus for a very irregular surface, the outer ear.
Materials and methods: We fabricated a bolus using a computed tomography (cT) scanner and evaluated its efficacy. The 
head of an alderson rando phantom was scanned with a cT scanner. Two 3D boluses of 5- and 10-mm thickness were de-
signed to fit on the surface of the ear. They were printed by the stratasys Objet260 connex3 using the malleable “rubber-like” 
photopolymer agilus. cT simulations of the rando phantom with and without the 3D and commercial high density boluses 
were performed to evaluate the dosimetric properties of the 3D bolus. The prescription dose to the outer ear was 50 Gy at 2 
Gy/fraction. 
results: We observed that the target coverage was slightly better with the 3D bolus of 10mm compared with the commercial 
one (D98% 98.2% vs. 97.6%).The maximum dose was reduced by 6.6% with the 3D bolus and the minimum dose increased by 
5.2% when comparing with the commercial bolus. In addition, the homogeneity index was better for the 3D bolus (0.041 vs. 
0.073).
conclusion: We successfully fabricated a customized 3D bolus for a very irregular surface. The target coverage and dosimetric 
parameters were at least comparable with a commercial bolus. Thus, the use of malleable materials can be considered for the 
fabrication of customized boluses in cases with complex anatomy.
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Introduction
Radiation therapy (RT) is one of the most 
common treatments for cancer. RT effectively 
treats cancer by using high-energy beams to pin-
point and destroy cancer cells. The interaction 
between incident high energy photons and elec-
trons from the body tissue produce secondary 
electrons. Chemical reactions induced by these 
secondary electrons are known as major molec-
ular mechanism of RT. Due to kinetic energy 
transmitted from the photon, deposition of the 
secondary electron occurs after a few millime-
ters of travel in the forward direction from the 
interaction point. Because there are no interac-
tion points upstream from the surface to produce 
secondary electrons, RT dose of the surface dose 
is low [1]. Electron conformal therapy has been 
used for treating superficial cancers, owing to 
the fact that it results in a specific dose distribu-
tion. In addition, the electron beam have a sharp 
distal fall off, reducing unnecessary irradiation 
to the underlying healthy normal tissue. How-
ever, inhomogeneous dose delivery can occur in 
the target volume owing to irregularities in the 
skin surface and varying target depths [2]. Con-
sequently, a bolus is widely used to enhance the 
target coverage for superficial targets. 
Several studies have demonstrated the clinical 
efficacy of the bolus in different settings [3, 4]. The 
University of Texas M.D. Anderson Cancer Cen-
ter [3] reported the outcome of 70 patients with 
non-metastatic angiosarcoma. Fifty out of 70 pa-
tients underwent RT. Tissue equivalent bolus mate-
rial was applied to the skin surface to ensure ad-
equate dose to the entire thickness of the dermal 
tissues and to minimize the dose to underlying 
brain tissue. They conclude that custom wax bolus 
or another similar device may be necessary to pro-
vide adequate dose build up to the skin surface. An 
Australian study [4] explored the effect of the chest 
wall bolus technique on chest wall recurrence. This 
was a retrospective cohort study of 254 patients 
treated with adjuvant postmastectomy RT between 
1993 and 2003. In all, 143 (56%) patients received 
RT with whole chest wall bolus, 88 (35%) patients 
with a parascar bolus, and 23 (9%) with no bolus. 
On multivariate analysis, whole chest wall bolus 
was found to be a significant predictor for early 
cessation of RT resulting from acute skin toxicity. 
In addition, a failure to complete RT because of 
acute skin toxicity was associated with chest wall 
recurrence.
A commercial bolus cannot easily be applied 
on irregular surfaces, where unwanted air gaps 
exist between the bolus and body surface, thereby 
resulting in decreased surface doses. In order to 
solve this issue, three-dimensional boluses (3D 
boluses) have been successfully fabricated and ap-
plied to Rando phantoms with the use of 3D print-
ing technologies [5]. This technique has been used 
for a variety of medical applications, including 
educational training tools [6]. In this regard, the 
application of 3D printing technology to radia-
tion oncology has formed a strong research focus 
[7, 8]. Burleson et al. [7] designed a custom 3D 
bolus to treat the Rando phantom nose. The agree-
ment between measured and calculated values was 
good, with 86.5% of data points passing gamma 
requirements of 2 mm distance to agreement and 
5% dose difference. In this context, we explore the 
RT application possibility of a 3D printed bolus 
made of malleable material for the very irregular 
shape of the outer ear. 
Materials and methods  
scanning and printing procedure 
The head of an Alderson Rando phantom (The 
Phantom Laboratory, Salem, NY, USA) was uti-
lized for the fabrication process. Next, the image 
data of the phantom were acquired with the use 
of Toshiba Aquileon LB (Toshiba Medical Systems 
Corporation) and exported to the workstation. The 
image data were reconstructed, and a customized 
3D bolus was designed and fabricated by a Stratasys 
Objet260 Connex3 using PolyJet technology (Stra-
tasys Ltd., Eden Prairie, MN, USA) with the mal-
leable ̀ rubber-like’ photopolymer Agilus (Stratasys, 
Eden Prairie, MN, USA). 3D boluses of 2 to 10 mm 
thickness were designed to fit onto the ear. The case 
was immobilized using a standard S-frame with 
a thermoplastic mask and clear headrests. Com-
puted tomography (CT) simulations of the Rando 
phantom with and without the 3D and commercial 
high density boluses were performed to evaluate 
the dosimetric properties of the 3D boluses. The CT 
images were acquired with a slice thickness of 2.5 
mm contiguously and the outer ear was delineated 
as the target (15 cc). 
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Treatment planning
Intensity-modulated RT plans were generated 
in the Eclipse treatment planning system version 
10.0 (Varian Medical System, Palo Alto, CA, USA) 
with the use of the Dose Volume Optimizer (DVO) 
optimization algorithm v.10.0 and the calculation 
Anisotropic Analytical algorithm (AAA) v.10.0. 
The prescription dose to the target (outer ear) was 
50 Gy at 2 Gy/fraction. The treatment machine was 
a Clinac DHX, 120 MLC millennium with 6 MV 
beam energy. Dosimetric parameters of 6 plans 
[2 without bolus, 1 with commercial bolus, and 3 
(5-mm, 10-mm, and 10-mm thickness + gel) with 
3D printed bolus] were assessed (Tab. 1). The RT 
plans consisted of 5 sliding window Intensity-Mod-
ulated Photon-Beam Therapy (IMRT) fields at gan-
try 0º, 35º, 70º, 105º and 140º. The collimator was 
set to 358º and the dose rate was 300 um/min. The 
objective functions used were adapted to each case 
to get the optimal results according to the clinical 
practice. 
To ensure adequate dose coverage, two ap-
proaches were “applied”, depending on whether or 
not there was a bolus. The plans with a bolus were 
prescribed to the mean dose (Dmean) according 
ICRU 83 [9]. A virtual target volume without a bo-
lus was created excluding the 3 mm closest to the 
skin surface. For the plan without a bolus, the goal 
was to cover 95% of the virtual target covered by 
95% of the prescription dose. The following do-
simetric parameters were estimated for all cases: 
maximal dose (Dmax), Dmean, minimum dose 
(Dmin), V95% (volume receiving at least 95% of 
the prescription dose), dose received by 2% of tar-
get volume (D2), D95, D98, and homogeneity index 
(HI) proposed in ICRU-83 [9].
Dosimetric characterization
For this purpose, we designed and printed flat 
boluses with different thicknesses. The attenuation 
and scatter properties of the 3D printed (malleable 
“rubber-like” photopolymer, Agilus©) and commer-
cial (poliorganosiloxano, eXaSkin©) boluses were 
physically evaluated for a 6-MV clinical photon 
beam on a water-equivalent RW3 slab phantom in 
three configurations: without a bolus, with a com-
mercial bolus (5 and 10 mm thickness), and with 
six 3D printed boluses (2 to 10 mm thickness), 
thus obtaining nine measures. We then selected 
the 5- and 10-mm 3D boluses for comparison with 
the commercial bolus. The irradiations were per-
formed delivering 300 monitor units (MU), with 
a dose rate of 400 MU/min, using a 10 × 10 cm2 
open field with 0-degree gantry angle at 1000 mm 
skin-to-source distance (SSD). A Gafchromic EBT3 
film (International Specialty Products, Wayne, NJ) 
were cut (2 × 3 cm) and placed below the boluses 
providing depth dose measurements. Measurement 
films were scanned 24 hours after irradiation using 
a desktop flat-bed transmission Epson Expression 
Scanner 10000 XL (Epson, Long Beach, CA). The 
film scanner was operated with a resolution of 72 
dpi in the 48-bit red-green-blue (RGB) mode. 
physical measurements 
To evaluate the calculation algorithm AAA for 
the 3D bolus, we irradiated a field of 10 cm × 10 cm 
with 300 MU and the gantry at 90º to get the per-
table 1. Dosimetric parameters of 6 plans (prescribed dose: 50 Gy): 2 without bolus, 1 with commercial bolus, and 3 with 
three-dimensional (3D) printed bolus
Parameter No bolus No bolus*
Commercial 
bolus
3D bolus  
(0.5 cm) 
3D bolus  
(1 cm)
3D bolus  
(1 cm) + gel
Dmax [Gy (%)] 60.5 (121) 59.4 (118.8) 54.2 (108.4) 55 (110) 51.7 (103.4) 51.7 (103.4)
Dmean [Gy (%)] 45.3 (90.6) 52.3 (104.6) 50 (100) 50 (100) 50 (100)  50 (100)
Dmin [Gy (%)] 7.8 (15.6) 40.2 (80.4) 45.2 (90.4) 44.1 (88.2) 47.8 (95.6) 47.9 (95.8)
V95% (%) 55.5 95.3 100 99.6 100 100
D2% [Gy (%)] 56.4 (111) 57 (114) 52.4 (104.8) 52.5 (105) 51.1 (102.4) 51.1 (102.4)
D95% [Gy (%)] 25.2 (112.8) 47.5 (95) 49.2 (98.4) 48.7 (97.4) 49.3 (98.6) 49.3 (98.6)
D98% [Gy (%)] 20.7 (41.4) 46.2 (92.4) 48.8 (97.6) 48.4 (96.8) 49.1 (98.2) 49.1 (98.2)
homogeneity 
index**
0.787 0.208 0.073 0.083 0.041 0.040
*Virtual target volume without bolus excluding the 3 mm closest to the skin surface; ** homogeneity index (hI) proposed in the International commission on 
radiation Units and Measurements report 83 [(D2% – D98%)/D50%]. an hI of zero indicates that the absorbed-dose distribution is almost homogeneous
Reports of Practical Oncology and Radiotherapy 2021, vol. 26, no. 2
https://journals.viamedica.pl/rpor214
cent depth dose (PDD) profile under the three fol-
lowing conditions in the Rando phantom: without 
a bolus, with a commercial bolus, and with the 3D 
boluses. Gafchromic EBT3 films (ISP Corporation, 
Wayne, NJ, USA) were cut and inserted along the 
horizontal direction in the phantom. After irradia-
tion, the films were scanned in the RGB mode with 
an Epson 10000XL flatbed scanner according to 
the manufacturer recommendations for the film. 
The scanned images were analyzed with the use of 
the Omnipro I’mRT Version 1.7 (IBA Dosimetry, 
Schwarzenbruck, Germany) package. The calibra-
tion curves of the EBT3 film were determined in 
the red channel. A more detailed description of the 
film dosimetry with the use of the Gafchromic EBT 
films was provided in a previous study [10]. For the 
analysis, film dose measurements were smoothed 
applying a Gaussian filter 3 × 3 and the percent-
age of points that meet the gamma value (5%, 3 
mm) < 1 was obtained. The PDD profiles corre-
sponding to the measured dose in the EBT film and 
the calculated dose in treatment planning system 
were compared. 
results
We fabricated the customized 3D bolus (Fig. 1). 
CT simulation indicated it fit the ear acceptably 
(Fig. 2). Due to the irregular shape of the outer ear 
anatomy, there was some air gap between the bolus 
and the phantom surface with the commercial bo-
lus (Fig. 2). We observed that the target coverage 
was slightly better with the 3D bolus of 10 mm 
compared with the commercial one (D98% 98.2% vs. 
97.6%; Tab. 1). The maximum dose was reduced 
by 6.6% with the 3D bolus and the minimum dose 
increased by 5.2% when comparing with the com-
mercial bolus. In addition, the homogeneity index 
was better for the 3D bolus (0.041 vs. 0.073; Tab. 1).
Table 2 shows the measured doses with the 2–10 
mm thickness 3D-bolus as well as those with the 
5–10 mm thickness commercial bolus. There was 
Figure 1. Three-dimensional (3D) printed customized bolus of the outer ear. A. View of the designed 3D bolus; b. printed 
result obtained with malleable material; c. smulation scan setup of the bolus on the rando phantom
a B c
a B
Figure 2. computed tomography scan showing (A) commercial bolus, and (b) three-dimensional printed customized bolus 
for the irregular shape of the outer ear. arrows indicate air gaps
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a 4% and 2% difference between the 3D-bolus and 
the commercial bolus when evaluating the 5 and 
10mm thickness, respectively.  
Figure 3 shows the isodose lines corresponding 
to the plans with and without the bolus. We observe 
that the target coverage is better with the 3D bolus 
and it is similar compared with the commercial 
bolus. Figure 4A shows the dose-volume histogram 
of the ear with and without the 3D bolus, and Table 
1 summarizes the relevant dosimetric parameters 
table 2. calculated doses with 2–10 mm thickness 3D-bolus and the measured doses with 5–10 mm thickness commercial 
bolus.












Figure 3. Isodose lines corresponding to the plans without (A) and with the commercial (b) and the three-dimensional 
printed customized (c) bolus
a B c
Figure 4. Dose volume histogram of the target corresponding to the plans with and without the bolus (A) and the percent 
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for all plans. Further, the PDD curves correspond-
ing to the measured dose in the EBT film and the 
calculated dose in treatment planning system were 
comparable (Fig. 4B).
Discussion
Megavoltage photon RT penetrates through 
the skin to irradiate deep-seated tumors, with 
skin-sparing property. The build-up effect is con-
sidered a major benefit because of the reduction 
in skin toxicity. Hence, to treat superficial lesions, 
a commercial bolus is commonly used in such situ-
ations to increase the surface dose in radiation on-
cology units [11]. In case of an irregular surface 
region of a patient, unwanted air gaps under the 
bolus might occur between the bolus and patient 
skin due to the malleability of bolus material. It has 
been reported that an air gap of 4 mm causes a re-
duction of dose to the basal layer of approximately 
0–4% depending on field size, angle of incidence 
and other patient specific parameters and a reduc-
tion of up to 10% could be seen at the basal cell 
layer for a 10 mm air gap [12]. Our pertinent find-
ings can be summarized as follows. First, the target 
coverage was similar and even slightly better with 
the 3D bolus compared with the commercial one. 
Second, the maximum dose was reduced with the 
3D bolus and the minimum dose increased when 
comparing with the commercial bolus. Finally, the 
homogeneity index was better for the 3D bolus.
Fujimoto et al. [13] customized a patient-specific 
3D bolus using a 3D printing technique and evalu-
ated its clinical feasibility for photon RT. The virtual 
target volume was delineated below the surface of 
the phantom in the vicinity of the nose. In the 
physical evaluation, the 3D-bolus provided effective 
dose coverage in the build-up region, which was 
equivalent to the commercial-bolus. With regard to 
the clinical feasibility and in agreement with us, the 
air gaps were lesser with the 3D-bolus when com-
pared to the commercial-bolus and the prescription 
dose could be delivered appropriately to the target 
volume. The 3D-bolus had potential use for air-gap 
reduction compared to the commercial-bolus and 
facilitated target-volume dose coverage and homo-
geneity improvement. In addition, there was not 
any dosimetric improvement when adding gel be-
tween the 3D-bolus and the ear surface. It seems 
that the air gaps between the body surface and the 
3D bolus were not large enough to cause a lack of 
electronic balance. Hence, it is not necessary to use 
this gel to fill the virtual space after the 3D bolus 
application. 
In algorithms that do not take heterogeneities 
into account, the calculation accuracy for commer-
cial boluses tends to be lower. For instance, the 
Eclipse planning system uses a dose volume opti-
mizer optimization algorithm for IMRT that does 
not optimize adequately in areas of low or high 
density. That could be the reason why dosimetric 
parameters with the 3D bolus are slightly better 
than those of the commercial high density bolus. 
The 3D bolus had a radiological density similar 
to water. Both the optimization algorithms and 
the calculation algorithms are precise in this set-
ting. The planning system appropriately assigns the 
Hounsfield number to its density and the calcula-
tion algorithm is valid.
The design of a 3D bolus with the use of CT 
scans leads to unwanted radiation exposure of the 
patient [14]. To be able to make the bolus with 
little patient involvement and in minimal time, it 
has been proposed that the patient does not need 
to have a second CT done with the printed bolus 
for treatment planning [7]. The printed bolus den-
sity is overridden in Eclipse with a Hounsfield unit 
number of 260. Then, the treatment plan can be cal-
culated on the new CT using the same delivery pa-
rameters. Others [5] have proposed the use of a 3D 
surface scanner for the 3D bolus fabrication to re-
duce unnecessary radiation exposure. Park et al. [5] 
successfully fabricated a customized 3D bolus for 
a nose using a 3D surface scanner instead of a CT 
scanner. In comparison with the process based on 
the CT scan, the fabrication process based on a 3D 
surface scanner is simple and less time-consuming 
because this approach can skip several steps in the 
normal process from the contouring of the body 
surface to the generation of the STL file. The target 
presented in this report is challenging due to the 
very irregular surface of the ear. Although a 3D sur-
face scanner could be used, the complex anatomy of 
the ear hinders the acquisition of images. The CT 
scanner improves overall image quality in this case. 
In addition, clinical information is crucial for the 
3D bolus design in order to have a more customized 
therapy.
Our dosimetric analysis in this study showed 
that satisfactory target coverage could be achieved 
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with the proposed 3D bolus. Moreover, our PDD 
analysis with EBT film confirmed that the bolus 
fabricated could increase the surface dose effec-
tively, and this dose was comparable with that of 
a commercial bolus. This is in agreement with prior 
studies focused mainly on the nose [5, 15]. Another 
benefit could be when the bolus should be replaced 
during the treatment for some reason [16]. The 3D 
bolus can be replaced fast and accurately reproduc-
ing the previous one, thus assuring equivalent treat-
ment reproducibility.
conclusion
We successfully fabricated a 3D bolus to cover 
a very irregular surface. The fabrication process 
was simple and fast. The bolus, made of malleable 
material, suitably fitted the surface, and the surface 
dose was sufficiently enhanced. The designed bolus 
is potentially useful for high-accuracy dose delivery 
through the reduction of unexpected air gaps in 
the case of irregularly shaped patient-skin surfaces. 
In addition, the 3D bolus can be replaced easily if 
necessary with the exact shape of the previous one. 
Thus, we believe that the use of a 3D bolus and mal-
leable materials can be seriously considered for the 
fabrication of customized boluses for very irregular 
surfaces.
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